Surgery Ev To Free Cash Flow from 2010 to 2024

SGRY Stock  USD 23.84  0.43  1.84%   
Surgery Partners EV To Free Cash Flow yearly trend continues to be fairly stable with very little volatility. EV To Free Cash Flow is likely to outpace its year average in 2024. EV To Free Cash Flow is a valuation metric comparing Surgery Partners' enterprise value to its free cash flow, used to evaluate whether Surgery Partners is undervalued or overvalued. View All Fundamentals
 
EV To Free Cash Flow  
First Reported
2010-12-31
Previous Quarter
33.58077985
Current Value
54.09
Quarterly Volatility
61.50382581
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Ev To Free Cash Flow Growth Pattern

Below is the plot of the Ev To Free Cash Flow of Surgery Partners over the last few years. It is a valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued. Surgery Partners' EV To Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Ev To Free Cash Flow10 Years Trend
Pretty Stable
   Ev To Free Cash Flow   
       Timeline  

Surgery Ev To Free Cash Flow Regression Statistics

Arithmetic Mean59.10
Geometric Mean43.55
Coefficient Of Variation104.06
Mean Deviation40.50
Median29.59
Standard Deviation61.50
Sample Variance3,783
Range209
R-Value0.20
Mean Square Error3,918
R-Squared0.04
Significance0.48
Slope2.69
Total Sum of Squares52,958

Surgery Ev To Free Cash Flow History

2024 54.09
2023 33.58
2022 66.61
2021 229.59
2020 21.05
2019 63.76
2018 26.36

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Ev To Free Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Free Cash Flow 33.58  54.09 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.